The Educated Patient Podcast: New Cholesterol Guidelines Emphasize Personalized Cardiovascular Risk

For decades, cholesterol management has largely focused on identifying problems and treating patients after cardiovascular disease has already developed. But according to Michael D. Shapiro, D.O., the inaugural Fred M. Parrish professor of cardiology and molecular medicine at Wake Forest University and a contributor to the new American Heart Association’s 2026 cholesterol guidelines, that approach is changing.

The latest recommendations reflect a growing shift toward prevention, with a stronger emphasis on identifying risk factors earlier in life and tailoring treatment plans to individual patients. Advances in genetics, imaging and blood testing have helped researchers better understand who may be at risk for heart disease long before symptoms appear.

One of the most significant changes is the focus on earlier cardiovascular risk assessment. Previous guidelines primarily evaluated risk beginning around age 40, but newer recommendations encourage more comprehensive assessments starting at age 30. These evaluations use updated risk calculators that estimate both 10-year and long-term cardiovascular risk, helping clinicians identify younger adults who may benefit from earlier intervention.

The guidelines also place greater emphasis on personalized risk factors beyond traditional cholesterol measurements. One example is lipoprotein(a), or Lp(a), an inherited form of cholesterol that can significantly increase cardiovascular risk. Because Lp(a) levels are largely determined by genetics and remain relatively stable throughout life, experts now recommend broader testing to identify individuals who may have inherited elevated risk.

Another important marker is high-sensitivity C-reactive protein, which measures inflammation in the body. Elevated inflammation has been linked to increased cardiovascular risk and may signal the need for lifestyle changes such as weight management, improved nutrition and increased physical activity.

While new diagnostic tools and biomarkers are expanding physicians’ ability to assess risk, Shapiro emphasized that lifestyle remains a cornerstone of prevention. Regular physical activity, maintaining a healthy weight, avoiding tobacco use and following a heart-healthy eating pattern continue to be among the most effective ways to lower cardiovascular risk.

Physical activity, in particular, may offer benefits across multiple areas of health. Exercise can help lower blood pressure, improve cholesterol levels, reduce blood sugar, enhance sleep quality and support mental well-being. Importantly, meaningful benefits do not require intense workouts. Even modest increases in daily movement can make a difference, especially for people who are currently inactive.

The updated guidelines also reinforce the importance of screening. Children should receive cholesterol testing between the ages of 9 and 11 to help identify inherited cholesterol disorders, while adults should continue periodic screening throughout life. For individuals with strong family histories of heart disease or genetic risk factors, earlier intervention may help prevent future cardiovascular events.

Shapiro believes the most important message for patients is simple: Know your numbers. Understanding cholesterol levels, blood pressure, blood sugar and other key health markers can provide valuable insight into cardiovascular risk and create opportunities to take action before heart disease develops.